period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.85,0.35,0.0,0.2916666666666667,[1],
1,1.2,0.85,0.35,0.0,0.2916666666666667,[1],The FDA is monitoring the emerging drug shortage situation closely. We encourage manufacturers to increase reporting on production levels and any potential disruptions.
2,1.3,0.925,0.375,0.0,0.28846153846153844,[1],The FDA is aware of an emerging shortage in the market and encourages manufacturers and stakeholders to enhance coordination and voluntary reporting. Patient care providers should monitor supplies closely and consider alternative treatments where feasible.
3,1.2,1.075,0.125,0.07499999999999996,0.10416666666666667,[1],The FDA is aware of an emerging supply issue and encourages stakeholders to report any significant disruptions. We are actively monitoring the situation and facilitating communication among industry participants.
